Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 5, 1999, Pages 446-456

  Secknus, Roger ^a,d   Darby, Gwendolyn H ^b   Chernosky, Ann ^a   Juvonen, Tatu ^c   Moore, Edward W ^b   Holzbach, R Thomas ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Apolipoprotein A I; Cholesterol; Gall bladder epithelium; Gallstones

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL;

ARTICLE; CELL MEMBRANE TRANSPORT; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CRYSTALLIZATION; GALLBLADDER EPITHELIUM; GALLSTONE FORMATION; HUMAN; HUMAN CELL; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL;

EID: 0033028356     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01881.x     Document Type: Article

References (49)

1. 1 Holzbach RT. Factors influencing cholesterol nucleation in bile. Hepatology 1984; 4: 173-6.
2. 2 Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE. Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J. Clin. Invest. 1984; 73: 35-45.
3. 3 Gallinger S, Taylor RD, Harvey PRC, Petrunka CN, Strasberg SM. Effect of mucus glycoprotein on nucleation time of human bile. Gastroenterology 1985; 89: 648-58.
4. 4 Upadhya GA, Harvey PRC, Strasberg SM. Effect of human biliary immunoglobulins on the nucleation of cholesterol. J. Biol. Chem. 1993; 268: 5193-200.
5. 1-acid glycoprotein, phospholipase C and aminopeptidase N. J. Lipid Res. 1993; 34: 1141-8.
6. 1-acid glycoprotein as a cholesterol crystallization promoter. Gastroenterology 1994; 106: 231-8.
7. 7 Yamashita G, Ginanni Corradini S, Secknus R et al. Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations. J. Lipid Res. 1995; 36: 1325-33.
8. 8 Offner GD, Gong D, Afdhal NH. Identification of a 130-kilodalton human biliary concanavalin-A binding protein as aminopeptidase-N. Gastroenterology 1994; 106: 755-62.
9. 9 Núñez L, Amigo L, Rigotti A et al. Cholesterol crystallization-promoting activity of aminopeptidase-N isolated from the vesicular carrier of biliary lipids. FEBS Lett. 1993; 329: 84-8.
10. 10 Ohya T, Schwarzendrube J, Busch N et al. Isolation of a human biliary glycoprotein inhibitor of cholesterol crystallization. Gastroenterology 1993; 104: 527-38.
11. 11 Busch N, Lammert F, Marschall H-U, Matern S. A new subgroup of lectin-bound biliary protein binds to cholesterol crystals, modifies crystal morphology and inhibits cholesterol crystalization. J. Clin Invest. 1995; 96: 3009-15.
12. 12 Secknus R, Yamashita G, Ginanni Corradini S et al. Purification and characterization of a novel human 15 kD cholesterol crystallization inhibitor protein in bile. J. Lab. Clin. Med. 1996; 127: 151-60.
13. 13 Kibe A, Holzbach RT, LaRusso NF, Mao SJT. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science 1984; 225: 514-16.
14. 14 Sewell RB, Mao SJT, Kawamoto T, LaRusso NF. Apolipoproteins of high, low, and very low density lipoproteins in human bile. J. Lipid Res. 1984; 24: 391-401.
15. 15 Swobodnik W, Wenk H, Janowitz P et al. Total biliary protein, mucus glycoproteins, cyclic AMP and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls. Scand. J. Gastroenterol. 1991; 26: 771-8.
16. 16 Hasegawa T, Makino I. Measurement of apolipoprotein AI in cholesterol gallstones and gallbladder bile of patients with gallstones. J. Gastroenterol. 1995; 30: 96-102.
17. 17 Purdum III PP, Ulissi A, Hylemon PB, Shiffman ML, Moore EW. Cultured human gallbladder epithelia. Methods and partial characterization of a carcinoma-derived model. Lab. Invest. 1993; 68: 345-53.
18. 18 Ulissi A, Purdum III PP, Moore EW. Vesicular phospholipid transport in cultured human gallbladder epithelia is dependent on vesicular size, epithelial confluency and presence of oxygen (Abstract). Hepatology 1993; 18: 95A.
19. 19 Eisenberg S. High density lipoprotein metabolism. J. Lipid Res. 1984; 25: 1017-58.
20. 20 Sviridov D, Fidge NH. Efflux of intracellular versus, plasma membrane cholesterol in HepG2 cells: Different availability and regulation by apolipoprotein A-I. J. Lipid Res. 1995; 36: 1887-96.
21. 21 Barbaras R, Puchois P, Pradines-Figuères A et al. Binding of apolipoproteins A to adipose cells: Role of receptor sites in cholesterol efflux and purification of binding protein(s). In: Malmendier CL, Alaupovic P, Brewer HBJ, eds. Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia, in vivo Kinetics. 285. New York: Plenum Press, 1991; 85-92.
22. 22 Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 1989; 9: 785-97.
23. 23 Tao S, Tazuma S, Kajiyama G. Apolipoprotein A-I stabilizes phospholipid lamellae and thus prolongs nucleation time in model bile systems: An ultrastructural study. Biochim. Biophys. Acta 1993; 1166: 25-30.
24. 24 Bisgaier CL, Glickman RM. Intestinal synthesis, secretion and transport of lipoproteins. Annu. Rev. Physiol. 1983; 45: 625-36.
25. 25 Eggerman TL, Hoeg JM, Meng MS, Tombragel A, Bojanovski D, Brewer Jr HB. Differential tissue-specific expression of human Apo A-I and Apo A-II. J. Lipid Res. 1991; 32: 821-828.
26. 26 Sonoyama K, Nishikawa H, Kiriyama S, Niki R. Cholestyramine and a fat-free diet lower apolipoprotein A-IV mRNA in jejunum and cholestyramine lowers apolipoprotein A-I mRNA in ileum of rats. J. Nutr. 1994; 124: 621-7.
27. 27 Aronow BJ, Lund SD, Brown TL, Harmony JA, Witte DP. Apolipoprotein J expression at fluid-tissue interfaces: Potential role in barrier cytoprotection, Proc. Natl Acad. Sci. USA 1993; 90: 725-9.
28. 28 Pattinson NP, Upton P, Ellingsen PJ, Chapman BA. Apolipoprotein localization in the human bile duct and gallbladder. Pathology 1990; 22: 55-60.
29. 29 Busch N, Matiuck N, Sahlin S, Pillay SP, Holzbach RT. Inhibition and promotion of cholesterol crystallization by protein fractions from normal human gallbladder bile. J. Lipid Res. 1991; 32: 695-702.
30. 30 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
31. 31 Pidgeon C, Marcus C, Alvarez F. Immobilized artificial membrane chromatography: Surface chemistry and applications. In: Kelly JW, Baldwin TO, eds. Applications of Enzyme Biotechnology. New York: Plenum Publishing Co. 1991; 201-20.
32. 32 Turley SD, Dietschy M. Re-evaluation of the 3α-hydroxysteroid dehydrogenase assay for total bile acids in bile. J. Lipid Res. 1978; 19: 924-8.
33. 4. Nature 1970; 227: 680-5.
34. 34 Morrissey JH. Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced sensitivity. Anal. Biochem. 1981; 117: 307-10.
35. 35 Busch N, Tokumu H, Holzbach RT. A sensitive method for determination of cholesterol growth using model solutions of supersaturated bile. J. Lipid Res. 1990; 31: 1903-9.
36. 36 Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J. Lipid Res. 1978; 19: 945-55.
37. 37 Mayer LD, Hope MJ, Cullis PR. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 1986; 858: 161-8.
38. 38 Edelstein C, Lewis LL, Shainoff JR, Naito H, Scanu AM. Isolation and characterization of a dog serum lipoprotein having apolipoprotein A-I as its predominant protein constituent. Biochemistry 1976; 15: 1934-41.
39. 39 Purdum III PP, Shamburek RD, Hylemon PB, Moore EW. Rapid phospholipid (PL) transfer across cultured human gallbladder epithelia (Abstract). Gastroenterology 1992; 102: A871.
40. 40 Yu PR, Chen Q, Biancani P, Behar J. Excess membrane cholesterol impairs gallbladder muscle contraction (Abstract). Gastroenterology 1995; 108: A442.
41. 41 Chen Q, Yu PR, Biancani P, Behar J. Excess membrane cholesterol alters membrane fluidity of gallbladder muscle cells (Abstract). Gastroenterology 1996; 110: A451.
42. 42 Hulme EC. Receptor-ligand interactions: A practical approach. Oxford, New York: IRL Press, 1992.
43. 43 Kaptein A, de Wit ECM, Printen HMG. Retinoids stimulate Apo A-I synthesis by induction of gene transcription in primary hepatocyte cultures from Cynomolgus monkey (Macaco fascicularis). Arterioscler. Thromb. 1993; 13: 1505-14.
44. 44 Elshourbagy NA, Boguski MS, Liao WSL, Jefferson LS, Gordon JI, Taylor JM. Expression of rat apolipoprotein A-IV and A-I genes, mRNA induction during development and in response to glucocorticoids and insulin. Proc. Natl Acad. Sci. USA 1985; 82: 8242-6.
45. 45 Archer TK, Tam S-P, Deeley RG. Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. J. Biol. Chem. 1986; 261: 5067-74.
46. 46 Staels B, van Tol A, Andreu T, Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler. Thromb. 1992; 12: 286-94.
47. 47 van Erpecum KJ, van Berge Henegouwen GP, Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990; 11: 1-6.
48. 48 van Erpecum KJ, Stolk MFJ, van den Broek AMWC, Renooij W, van de Heijning BJM, van Berge Henegouwen GP. Bile concentration promotes nucleation of cholesterol monohydrate crystals by increasing the cholesterol concentration in the vesicles. Eur. J. Clin. Invest. 1993; 23: 283-8.
49. 49 Purdum III PP, Afdhal NH, Rege RV, Moore EW. Effect of mucus gel layers on phospholipid transfer across cultured human gallbladder epithelia (CHGE) (Abstract). Hepatology 1994; 20: 115A.